Check-Points

  • Check-Direct CPE

    Active Screening for Carbapenemases
    by Real-Time PCR

    KPC - OXA-48 - VIM - NDM Rapid Molecular Detection of Carbapenemase-Producing Enterobacteriaceae Kits for 48 reactions now available

    Download brochure (PDF) ›
  • Check-MDR Real-Time PCR

    Real-Time detection of carbapenemases
    and ESBLs

    Detect carbapenemases or ESBL with high sensitivity and specificity Objective results in 4.5 hours & use in your Real-Time labflow Kits for 24 reactions now available

    More info ›
  • Check-MDR CT platform

    Microarray identification of carbapenemase, ESBL and AmpC genes

    Confirm suspected multidrug resistance Improve your epidemiological insight Exclude outbreaks

    More info ›
Our products

Check-Points offers a range of rapid molecular assays Our products support you in identifying and controlling the spread of carbapenemases, ESBLs and AmpCs & rapid molecular serotyping of Salmonella.

antibiotic resistance

Antibiotic Resistance

The presence of multidrug resistance (MDR) in Gram-negative bacteria makes infections caused by these bacteria extremely difficult to treat. Such bacteria, which produce carbapenemases, ESBLs and AmpCs, are now increasing sharply and spreading worldwide.

Real-Time PCR

Check-Points Reader

Detect the clinically most prevalent carbapenemases or ESBLs in just 4.5 hours. By utilizing existing Real-Time equipment and a standard thermal profile, the Check-MDR Real-Time PCR assays can easily be used in your Real-Time labflow.

Microarray

Check&Trace kit

Pinpoint the presence of multidrug resistance genes through simultaneous analysis of up to 100 specific DNA markers. The Check-MDR CT products are the first to detect carbapenemases, ESBLs and AmpCs in a single test.

24th ECCMID

More info 10-13 May

Meet us at ECCMID in Barcelona at booth #49

ECCMID

Recent News

Testimonials

"It provided definitive results within the same working day, allowing rapid implementation of isolation measures and appropriate antibiotic treatment" Naas et al. Antimicrobial Agents